cbdMD Stock Trading Down After Announcing Deal With IM Cannabis Corp. To Enter Israel
Cannabidiol brand cbdMD, Inc. (NYSE: YCBD) has teamed up with IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) to enter the Israeli market.
cbdMD Signs Exclusive Agreement With IM Cannabis Corp. Granting IM Exclusive Right To Import, Sell, Distribute And Market cbdMD’s Products In Israel
cbdMD, Inc. (NYSE:YCBD, YCBDpA)), one of the leading, and most highly trusted and recognized CBD companies, announced today the signing of a binding letter of intent with IM Cannabis Corp. (CSE:IMCC, NASDAQ:IMCC)
Israel’s Cannabis Market: What Investors & Entrepreneurs Need To Know
Israel is a leader in cannabis, be it research and or in the emerging marketplace.
Numerous research breakthroughs have occurred in Israel. One of the most notable cannabis researchers is Dr. Rafael Mechoulam, who along with his team first identified THC and other active compounds in cannabis decades ago.
The Week In Cannabis: Tilray’s Huge Week, Colin Hanks, Allen Iverson, Seth Rogen And More
Below is a recap of the main news related to the cannabis industry and markets for the week ending July 30, 2021.
Contents
IM Cannabis Sees Q2 2021 Revs $11M-$12M
IMC expects its net revenue in the second quarter of 2021 to be in the range of $11 million to $12 million, an approximate 30% sequential increase from the first quarter. As
Flowr Cannabis Co Announces $7.01M Offering Of Units And $1M In Direct Placement, Aims To Partly Repay Its Debt
The Flowr Corporation (TSXV: FLWR) (OTC: FLWPF) announced Thursday a $7.01 million worth offering of units.
Weed Companies On The Move: IM Cannabis Completes Purchase Of MYM Nutraceuticals
Multi-country medical and recreational cannabis operator, IM Cannabis (CSE: IMCC) (NASDAQ: IMCC) confirmed Friday it has completed its
IM Cannabis Clinical Survey Reports Efficacy Of Its Branded Strains For Conditions Such As PTSD, Insomnia, Back Pain, IBS
IM Cannabis Corp. (NASDAQ: IMCC) (CSE: IMCC) released promising results Thursday of a survey that evaluated the effectiveness of seven company-branded medical cannabis strains in treating seven health conditions.
70 Biggest Movers From Yesterday
Gainers
Nemaura Medical Inc. (NASDAQ: NMRD) shares surged 135.3% to close at $11.06 on Wednesday after the company receipt of a purchase order for 5,000 sugarBEAT transmitters and 200,000 sugarBEAT sensors from its U.K. licensee, DB Ethitronix Ltd.